1. Home
  2. UNB vs INDP Comparison

UNB vs INDP Comparison

Compare UNB & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

HOLD

Current Price

$23.76

Market Cap

121.6M

Sector

Finance

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.13

Market Cap

125.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNB
INDP
Founded
1891
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.6M
125.2M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
UNB
INDP
Price
$23.76
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.8K
788.3K
Earning Date
04-15-2026
05-11-2026
Dividend Yield
5.76%
N/A
EPS Growth
25.52
N/A
EPS
1.25
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.65
$0.92
52 Week High
$26.54
$8.57

Technical Indicators

Market Signals
Indicator
UNB
INDP
Relative Strength Index (RSI) 45.43 38.42
Support Level $23.75 $0.92
Resistance Level $24.56 $2.95
Average True Range (ATR) 0.40 0.17
MACD -0.02 0.06
Stochastic Oscillator 30.00 31.06

Price Performance

Historical Comparison
UNB
INDP

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: